Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Benitec Biopharma Ltd completes A$31.5 million private placement

Tuesday, 15 Apr 2014 08:30am EDT 

Benitec Biopharma Ltd:Completes previously announced private placement of up to about 29.4 mln of its ordinary shares at a price of A$1.07 per ordinary share.Says it will receive a total of about A$31.5 mln.Proceeds will also be used to advance other programs in its pipeline, with a particular emphasis on the lung cancer, age-related macular degeneration, and hepatitis B programs. 

Company Quote

24 Apr 2015